Authors' Response: The disastrous triple hit-taxane-induced retinal toxicity in a patient with breast cancer and a pathogenic USH2A variant.
作者信息
Moreker Mayur R
机构信息
Department of Ophthalmology, Bombay Hospital Institute of Medical Sciences, Mumbai, Maharashtra, India.
出版信息
Indian J Ophthalmol. 2024 Dec 1;72(12):1835-1836. doi: 10.4103/IJO.IJO_2079_24. Epub 2024 Nov 29.
Abstract
摘要
相似文献
1
Authors' Response: The disastrous triple hit-taxane-induced retinal toxicity in a patient with breast cancer and a pathogenic USH2A variant.作者回复：一名患有乳腺癌且携带致病性USH2A变异的患者中，紫杉烷导致的灾难性三重打击视网膜毒性。
Indian J Ophthalmol. 2024 Dec 1;72(12):1835-1836. doi: 10.4103/IJO.IJO_2079_24. Epub 2024 Nov 29.
2
Taxane-induced retinal toxicity in a pathogenic USH2A variant carrier.紫杉烷诱发的致病性USH2A变异携带者视网膜毒性。
Indian J Ophthalmol. 2024 Dec 1;72(12):1834-1835. doi: 10.4103/IJO.IJO_914_24. Epub 2024 Nov 29.
3
A Comparative Evaluation of the Genetic Variant Spectrum in the Gene in Russian Patients with Isolated and Syndromic Forms of Retinitis Pigmentosa.俄罗斯孤立型和综合征型色素性视网膜炎患者基因中遗传变异谱的比较评估。
Int J Mol Sci. 2024 Nov 13;25(22):12169. doi: 10.3390/ijms252212169.
4
Modeling Retinitis Pigmentosa: Retinal Organoids Generated From the iPSCs of a Patient With the USH2A Mutation Show Early Developmental Abnormalities.视网膜色素变性建模：由患有USH2A突变患者的诱导多能干细胞生成的视网膜类器官显示早期发育异常。
Front Cell Neurosci. 2019 Aug 7;13:361. doi: 10.3389/fncel.2019.00361. eCollection 2019.
5
Taxane-containing regimens for metastatic breast cancer.用于转移性乳腺癌的含紫杉烷方案。
Cochrane Database Syst Rev. 2015 Jun 10;2015(6):CD003366. doi: 10.1002/14651858.CD003366.pub3.
6
Taxanes for adjuvant treatment of early breast cancer.紫杉烷类用于早期乳腺癌的辅助治疗。
Cochrane Database Syst Rev. 2019 Sep 2;9(9):CD004421. doi: 10.1002/14651858.CD004421.pub3.
7
A detailed clinical and molecular survey of subjects with nonsyndromic USH2A retinopathy reveals an allelic hierarchy of disease-causing variants.对非综合征性USH2A视网膜病变患者进行的详细临床和分子调查揭示了致病变异的等位基因层次结构。
Eur J Hum Genet. 2015 Oct;23(10):1318-27. doi: 10.1038/ejhg.2014.283. Epub 2015 Feb 4.
8
Unravelling the pathogenic role and genotype-phenotype correlation of the USH2A p.(Cys759Phe) variant among Spanish families.揭示西班牙家族中 USH2A p.(Cys759Phe) 变异的致病作用和基因型-表型相关性。
PLoS One. 2018 Jun 18;13(6):e0199048. doi: 10.1371/journal.pone.0199048. eCollection 2018.
9
Taxane containing regimens for metastatic breast cancer.含紫杉烷的转移性乳腺癌治疗方案。
Cochrane Database Syst Rev. 2005 Apr 18(2):CD003366. doi: 10.1002/14651858.CD003366.pub2.
10
Real-world data of HER2-negative early breast cancer patients treated with anthracycline and/or taxane regimens in Japan.日本接受蒽环类药物和/或紫杉烷类方案治疗的 HER2 阴性早期乳腺癌患者的真实世界数据。
Breast Cancer. 2024 Jul;31(4):581-592. doi: 10.1007/s12282-024-01572-8. Epub 2024 Apr 29.
本文引用的文献
1
Taxane-induced retinal toxicity in a pathogenic USH2A variant carrier.紫杉烷诱发的致病性USH2A变异携带者视网膜毒性。
Indian J Ophthalmol. 2024 Dec 1;72(12):1834-1835. doi: 10.4103/IJO.IJO_914_24. Epub 2024 Nov 29.
2
The Significance of the Ocular Adverse Effect Induced by Systemic Taxane Application.全身应用紫杉烷类药物引起的眼部不良反应的意义。
Front Biosci (Landmark Ed). 2022 May 31;27(6):171. doi: 10.31083/j.fbl2706171.
3
USH2A-retinopathy: From genetics to therapeutics.USH2A 相关性视网膜病变：从遗传学治疗学。
Exp Eye Res. 2020 Dec;201:108330. doi: 10.1016/j.exer.2020.108330. Epub 2020 Oct 27.
4
Non-syndromic retinitis pigmentosa.非综合征性视网膜色素变性。
Prog Retin Eye Res. 2018 Sep;66:157-186. doi: 10.1016/j.preteyeres.2018.03.005. Epub 2018 Mar 27.
5
How Taxol/paclitaxel kills cancer cells.紫杉醇是如何杀死癌细胞的。
Mol Biol Cell. 2014 Sep 15;25(18):2677-81. doi: 10.1091/mbc.E14-04-0916.
6
Enrichment of LOVD-USHbases with 152 USH2A genotypes defines an extensive mutational spectrum and highlights missense hotspots.用152种USH2A基因型丰富LOVD-USH数据库定义了广泛的突变谱并突出了错义热点。
Hum Mutat. 2014 Oct;35(10):1179-86. doi: 10.1002/humu.22608. Epub 2014 Jul 15.
7
Paclitaxel maculopathy.紫杉醇致黄斑病变
Arch Ophthalmol. 2007 May;125(5):709-10. doi: 10.1001/archopht.125.5.709.
Zotero 插件